title: Complete remission of severe chronic recurrent angioedema of unknown cause with omalizumab.
authors.forename: Antonie
authors.initials: A
authors.lastname: von Websky
authors.forename: Kristian
authors.initials: K
authors.lastname: Reich
authors.forename: Volker
authors.initials: V
authors.lastname: Steinkraus
authors.forename: Kristine
authors.initials: K
authors.lastname: Breuer
mesh_terms: D000799:Angioedema / Q000175:diagnosis* / Q000209:etiology / Q000517:prevention & control*; D018926:Anti-Allergic Agents / Q000008:administration & dosage; D000888:Antibodies, Anti-Idiotypic / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D002908:Chronic Disease; D006801:Humans; D007279:Injections, Subcutaneous; D000069444:Omalizumab; D012074:Remission Induction / Q000379:methods; D055502:Secondary Prevention; D016896:Treatment Outcome
chemical_list: D018926:Anti-Allergic Agents; D000888:Antibodies, Anti-Idiotypic; D061067:Antibodies, Monoclonal, Humanized; D000069444:Omalizumab